Finnish Dx Firm Blueprint Genetics Raises €14M

Jul 13, 2017

|

NEW YORK (GenomeWeb) – Blueprint Genetics this week announced it raised €14 million ($16 million) in a new financing round, bringing the total investment in its history to €23 million.

The financing round was led by new investors Creathor Venture and MedTech Innovation Partners. Existing investors Inventure and Pontos Group also participated.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Finnish Dx Firm Blueprint Genetics Raises €14M

To read the full story....

Breaking News

GenScript Biotech, IES Diagnostics Partner to Distribute SARS-CoV-2 Antibody Kit

NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date

RenalytixAI, Joslin Diabetes Center Ink Kidney Disease IP Agreement

Calciscon Raises $2.7M in Series A Round

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

What's Popular?

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

Calciscon Raises $2.7M in Series A Round

Ortho Clinical Diagnostics Gets Additional CE Mark for Coronavirus Antigen Test

Sponsorships